4//SEC Filing
Thomas Isiah III 4
Accession 0001493152-21-011747
CIK 0001622244other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 1:37 PM ET
Size
5.6 KB
Accession
0001493152-21-011747
Insider Transaction Report
Form 4
Thomas Isiah III
DirectorCEO and Chairman
Transactions
- Award
Series B Preferred Stock
2021-05-17$15.00/sh+33,334$500,010→ 133,334 total(indirect: See Footnote)Exercise: $0.15From: 2021-05-17→ Common Stock (3,333,400 underlying)
Footnotes (2)
- [F1]The Series B Preferred Stock does not have an expiration date.
- [F2]The securities were purchased by ISIAH International LLC. The reporting person owns all of the membership interests in ISIAH International LLC, and is its Chairman and Chief Executive Officer.
Documents
Issuer
One World Pharma, Inc.
CIK 0001622244
Entity typeother
Related Parties
1- filerCIK 0001807331
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 1:37 PM ET
- Size
- 5.6 KB